Stoke Therapeutics, Inc. ($STOK)
Hoitt Jason โ Chief Patient Officer
Shares
748
Price
$33.38
Total Value
$24,964.80
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Mar 24, 2026
EPS:Est: -0.93
Revenue:Est: $6.24M
Transaction Details
| Insider | Hoitt Jason |
|---|---|
| Title | Chief Patient Officer |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 748 |
| Price per Share | $33.38 |
| Total Value | $24,964.80 |
| Shares Owned After | 12,207 |
| Derivative | No |
| Accession Number | 0001762572-26-000006 |
| Document | View SEC Filing |